SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-008937
Filing Date
2024-02-22
Accepted
2024-02-22 07:58:04
Documents
20
Period of Report
2024-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20022087_8k.htm   iXBRL 8-K 37624
2 EXHIBIT 5.1 ef20022087_ex5-1.htm EX-5.1 16999
3 EXHIBIT 10.1 ef20022087_ex10-1.htm EX-10.1 240325
4 EXHIBIT 99.1 ef20022087_ex99-1.htm EX-99.1 283450
8 image0.jpg GRAPHIC 8451
9 image00001.jpg GRAPHIC 2847
10 image00003.jpg GRAPHIC 2550
  Complete submission text file 0001140361-24-008937.txt   823383

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA insm-20240222.xsd EX-101.SCH 3860
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20240222_lab.xml EX-101.LAB 22547
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20240222_pre.xml EX-101.PRE 16041
21 EXTRACTED XBRL INSTANCE DOCUMENT ef20022087_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 24662354
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)